vs

Side-by-side financial comparison of IHS Holding Ltd (IHS) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

IHS Holding Ltd is the larger business by last-quarter revenue ($254.0M vs $197.9M, roughly 1.3× REPLIGEN CORP). On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 0.1%). IHS Holding Ltd produced more free cash flow last quarter ($178.6M vs $17.6M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs -22.0%).

IHS Towers is one of the largest independent owners, operators and developers of shared communications infrastructure in the world, with operations across Africa and Latin America. It is the fifth-largest independent multinational tower company in the world.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

IHS vs RGEN — Head-to-Head

Bigger by revenue
IHS
IHS
1.3× larger
IHS
$254.0M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+13.6% gap
RGEN
13.6%
0.1%
IHS
More free cash flow
IHS
IHS
$161.0M more FCF
IHS
$178.6M
$17.6M
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
-22.0%
IHS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IHS
IHS
RGEN
RGEN
Revenue
$254.0M
$197.9M
Net Profit
$13.3M
Gross Margin
83.6%
52.5%
Operating Margin
9.0%
Net Margin
6.7%
Revenue YoY
0.1%
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IHS
IHS
RGEN
RGEN
Q4 25
$254.0M
$197.9M
Q3 25
$455.1M
$188.8M
Q2 25
$433.3M
$182.4M
Q1 25
$439.6M
$169.2M
Q4 24
$253.8M
$174.1M
Q3 24
$420.3M
$154.9M
Q2 24
$435.4M
$154.1M
Q1 24
$417.7M
$151.3M
Net Profit
IHS
IHS
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$147.4M
$14.9M
Q2 25
$32.3M
$14.9M
Q1 25
$30.7M
$5.8M
Q4 24
$-30.3M
Q3 24
$-205.7M
$-654.0K
Q2 24
$-124.3M
$3.3M
Q1 24
$-1.6B
$2.1M
Gross Margin
IHS
IHS
RGEN
RGEN
Q4 25
83.6%
52.5%
Q3 25
47.5%
53.2%
Q2 25
51.3%
50.0%
Q1 25
51.4%
53.6%
Q4 24
72.1%
26.1%
Q3 24
52.0%
50.0%
Q2 24
52.5%
49.8%
Q1 24
39.1%
49.5%
Operating Margin
IHS
IHS
RGEN
RGEN
Q4 25
9.0%
Q3 25
35.1%
8.9%
Q2 25
33.8%
7.6%
Q1 25
37.1%
3.9%
Q4 24
-17.7%
Q3 24
29.9%
-5.1%
Q2 24
34.0%
1.0%
Q1 24
-1.7%
1.3%
Net Margin
IHS
IHS
RGEN
RGEN
Q4 25
6.7%
Q3 25
32.4%
7.9%
Q2 25
7.5%
8.2%
Q1 25
7.0%
3.4%
Q4 24
-17.4%
Q3 24
-48.9%
-0.4%
Q2 24
-28.5%
2.2%
Q1 24
-372.8%
1.4%
EPS (diluted)
IHS
IHS
RGEN
RGEN
Q4 25
$0.24
Q3 25
$0.44
$0.26
Q2 25
$0.10
$0.26
Q1 25
$0.10
$0.10
Q4 24
$-0.55
Q3 24
$-0.61
$-0.01
Q2 24
$-0.36
$0.06
Q1 24
$-4.67
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IHS
IHS
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$825.7M
$767.6M
Total DebtLower is stronger
$3.1B
$542.2M
Stockholders' EquityBook value
$-89.8M
$2.1B
Total Assets
$4.5B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IHS
IHS
RGEN
RGEN
Q4 25
$825.7M
$767.6M
Q3 25
$647.6M
$748.7M
Q2 25
$531.8M
$708.9M
Q1 25
$629.0M
$697.2M
Q4 24
$578.0M
$757.4M
Q3 24
$397.5M
$784.0M
Q2 24
$445.7M
$809.1M
Q1 24
$333.2M
$780.6M
Total Debt
IHS
IHS
RGEN
RGEN
Q4 25
$3.1B
$542.2M
Q3 25
$3.3B
$537.9M
Q2 25
$3.2B
Q1 25
$3.4B
Q4 24
$3.3B
$525.6M
Q3 24
$3.5B
Q2 24
$3.6B
Q1 24
$3.5B
Stockholders' Equity
IHS
IHS
RGEN
RGEN
Q4 25
$-89.8M
$2.1B
Q3 25
$38.1M
$2.1B
Q2 25
$-98.4M
$2.1B
Q1 25
$-184.4M
$2.0B
Q4 24
$-314.4M
$2.0B
Q3 24
$-284.7M
$2.0B
Q2 24
$-308.3M
$2.0B
Q1 24
$-163.2M
$2.0B
Total Assets
IHS
IHS
RGEN
RGEN
Q4 25
$4.5B
$2.9B
Q3 25
$4.7B
$2.9B
Q2 25
$4.5B
$2.9B
Q1 25
$4.4B
$2.9B
Q4 24
$4.2B
$2.8B
Q3 24
$4.6B
$2.8B
Q2 24
$4.5B
$2.9B
Q1 24
$4.6B
$2.8B
Debt / Equity
IHS
IHS
RGEN
RGEN
Q4 25
0.26×
Q3 25
85.85×
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IHS
IHS
RGEN
RGEN
Operating Cash FlowLast quarter
$246.9M
$25.7M
Free Cash FlowOCF − Capex
$178.6M
$17.6M
FCF MarginFCF / Revenue
70.3%
8.9%
Capex IntensityCapex / Revenue
26.9%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$718.7M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IHS
IHS
RGEN
RGEN
Q4 25
$246.9M
$25.7M
Q3 25
$251.3M
$48.1M
Q2 25
$237.7M
$28.6M
Q1 25
$200.3M
$15.0M
Q4 24
$344.4M
$39.2M
Q3 24
$174.5M
$49.3M
Q2 24
$134.7M
$42.2M
Q1 24
$75.8M
$44.7M
Free Cash Flow
IHS
IHS
RGEN
RGEN
Q4 25
$178.6M
$17.6M
Q3 25
$189.2M
$43.4M
Q2 25
$197.7M
$21.5M
Q1 25
$153.2M
$11.4M
Q4 24
$282.9M
$33.6M
Q3 24
$122.3M
$42.3M
Q2 24
$74.2M
$37.4M
Q1 24
$14.8M
$36.4M
FCF Margin
IHS
IHS
RGEN
RGEN
Q4 25
70.3%
8.9%
Q3 25
41.6%
23.0%
Q2 25
45.6%
11.8%
Q1 25
34.8%
6.8%
Q4 24
111.5%
19.3%
Q3 24
29.1%
27.3%
Q2 24
17.0%
24.3%
Q1 24
3.5%
24.0%
Capex Intensity
IHS
IHS
RGEN
RGEN
Q4 25
26.9%
4.1%
Q3 25
13.6%
2.5%
Q2 25
9.2%
3.9%
Q1 25
10.7%
2.1%
Q4 24
24.2%
3.2%
Q3 24
12.4%
4.5%
Q2 24
13.9%
3.1%
Q1 24
14.6%
5.5%
Cash Conversion
IHS
IHS
RGEN
RGEN
Q4 25
1.93×
Q3 25
1.70×
3.23×
Q2 25
7.36×
1.92×
Q1 25
6.52×
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons